XRHealth is expanding its therapeutic platform beyond VR with AR glasses designed for live, clinician-guided telehealth — care delivered through the patient’s eyes, inside the patient’s environment. Platform availability is targeted for Q4 2026.
On September 16, 2026, Boston-based therapeutic XR company XRHealth announced a new AR Glasses solution for real-time, clinician-guided telehealth. The release, distributed via Business Wire and carried by trade wires the same morning, positions augmented reality as a complement to the company’s existing VR-based remote care stack rather than a replacement for it.
What the company says the glasses do
According to the announcement, patients wear lightweight AR glasses during a telehealth session while remaining present in their physical surroundings. Through the XRHealth platform, a clinician can join remotely in real time, communicate with the patient, and guide activities while the user continues to see and interact with their environment.
XRHealth frames that as a shift from screen-mediated video visits toward contextual, interactive remote care — “care delivered through the patient’s eyes and within the patient’s environment,” in the company’s wording. CEO Eran Orr said traditional telehealth “meant putting a camera between the clinician and the patient,” and argued AR can begin to remove that barrier by letting clinicians understand care from the patient’s perspective.
Where it fits: rehab, OT/PT, behavioral health
XRHealth lists potential applications spanning rehabilitation, physical and occupational therapy, behavioral health, remote patient support, and guided exercises — use cases where movement, environment, and real-world task performance matter. The company says the AR layer is designed to sit alongside its broader immersive healthcare platform and clinical services, giving care teams another option for how and where a patient receives care.
That continuity matters for readers tracking enterprise XR: XRHealth already markets FDA-registered immersive devices, digital therapeutic programs, and licensed clinicians across 22 U.S. states, with coverage pathways that include Medicare Part B and VA programs. Today’s news does not restate a new FDA clearance for the AR glasses themselves; it describes a platform expansion into AR-enabled telehealth sessions.
Timing and what is still unknown
XRHealth says it will introduce the AR Glasses solution as part of its platform beginning in Q4 2026. The September 16 release does not name a hardware OEM, publish a consumer or clinic list price, or detail sensor/display specs. Until those arrive, the story is a clinical-workflow announcement more than a headset teardown.
For Metaverse Watcher readers, the beat is clear: therapeutic XR vendors are treating AR glasses as a way to keep patients in the real world while still giving clinicians a live spatial channel — the inverse of VR’s “transport the patient” model. Hardware details will decide whether this stays a platform feature or becomes a shipment story.
Sources: MarketMinute / Business Wire (Sep 16, 2026); XRHealth.